Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model

Prostate

Volumn 69, Issue 7, 2009, Pages 755-760

  Yeh, I Tien ^a,b   Reddick, Robert L ^a   Kumar, Addanki Pratap ^a  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Epithelial stromal tumor; Phyllodes tumor; Prostate cancer model; Seminal vesicle malignancy; TRAMP

Indexed keywords

CYTOKERATIN; DESMIN; KI 67 ANTIGEN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPSY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; SEMINAL VESICLE; STROMA CELL; UROGENITAL SYSTEM; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; MALE; PATHOLOGY; PROSTATE TUMOR; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ADENOCARCINOMA; ANIMALS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; PROSTATIC NEOPLASMS; SEMINAL VESICLES;

EID: 65449132455     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20924     Document Type: Article

References (16)

1. Kumar AP, Bhaskaran S, Ganapathy M, Crosby K, Davis MD, Kochunov P, Schoolfield J, Yeh IT, Troyer DA, Ghosh R. Akt/ cAMP-responsive element binding protein/cyclin D1 network: A novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract. Clin Cancer Res 2007; 13(9):2784-2794.
2. Garcia GE, Wisniewski HG, Lucia MS, Arevalo N, Slaga TJ, Kraft SL, Strange R, Kumar AP. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: Role of tumor necrosis factor-alpha-stimulated gene 6. Clin Cancer Res 2006;12(3 Pt 1):980-988.
3. Gingrich JR, Barrios RJ, Foster BA, Greenberg NM. Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis 1999;2(2):70-75. (Pubitemid 29259935)
4. Tani Y, Suttie A, Flake GP, Nyska A, Maronpot RR. Epithelialstromal tumor of the seminal vesicles in the transgenic adenocarcinoma mouse prostate model. Vet Pathol 2005;42(3):306-314. (Pubitemid 40704821)
5. Kaplan-Lefko PJ, Chen TM, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ, Maddison LA, Foster BA, Greenberg NM. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 2003;55(3):219-237. (Pubitemid 36532401)
6. Shabaik A. Nonepithelial tumors and tumor-like lesions of the prostate gland. Crit Rev Clin Lab Sci 2003;40(4):429-472. (Pubitemid 37204501)
7. Agrawal V, Sharma D, Wadhwa N. Case report: Malignant phyllodes tumor of prostate. Int Urol Nephrol 2003;35(1):37-39.
8. Fain JS, Cosnow I, King BF, Zincke H, Bostwick DG. Cystosarcoma phyllodes of the seminal vesicle. Cancer 1993;71(6):2055-2061. (Pubitemid 23068556)
9. Hoshi A, Nakamura E, Higashi S, Segawa T, Ito N, Yamamoto S, Kamoto T, Ogawa O. Epithelial stromal tumor of the seminal vesicle. Int J Urol 2006;13(5):640-642. (Pubitemid 43760440)
10. McCarthy RP, Zhang S, Bostwick DG, Qian J, Eble JN, Wang M, Lin H, Cheng L. Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. Am J Pathol 2004;165(4):1395-1400. (Pubitemid 39297743)
11. Sawyer EJ, Hanby AM, Ellis P, Lakhani SR, Ellis IO, Boyle S, Tomlinson IP. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am J Pathol 2000;156(3):1093-1098. (Pubitemid 30626967)
12. Chiaverotti T, Couto SS, Donjacour A, Mao JH, Nagase H, Cardiff RD, Cunha GR, Balmain A. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.Am J Pathol 2008;172(1):236-246.
13. Huss WJ, Gray DR, Tavakoli K, Marmillion ME, Durham LE, Johnson MA, Greenberg NM, Smith GJ. Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model. Neoplasia 2007; 9(11):938-950. (Pubitemid 350086439)
14. Erickson LA, Lloyd RV. Practical markers used in the diagnosis of endocrine tumors. Adv Anat Pathol 2004;11(4):175-189.
15. Alkushi A, Irving J, Hsu F, Dupuis B, Liu CL, Rijn M, Gilks CB. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch 2003;442(3):271-277. (Pubitemid 36399222)
16. Besnard V, Wert SE, Hull WM, Whitsett JA. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr Patterns 2004;5(2):193-208. (Pubitemid 39618928)